Heartflow (NASDAQ:HTFL) Trading Down 8.5% – Should You Sell?

by · The Markets Daily

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) dropped 8.5% during trading on Monday . The stock traded as low as $29.28 and last traded at $29.50. Approximately 354,549 shares changed hands during mid-day trading, a decline of 24% from the average daily volume of 465,698 shares. The stock had previously closed at $32.25.

Analysts Set New Price Targets

HTFL has been the topic of several research analyst reports. Wall Street Zen upgraded shares of Heartflow to a “hold” rating in a research note on Saturday, August 16th. Piper Sandler initiated coverage on shares of Heartflow in a research report on Tuesday, September 2nd. They issued an “overweight” rating and a $38.00 target price for the company. Stifel Nicolaus increased their price target on Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, November 13th. Zacks Research raised Heartflow to a “hold” rating in a report on Wednesday, September 3rd. Finally, JPMorgan Chase & Co. increased their target price on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $38.60.

Check Out Our Latest Analysis on HTFL

Heartflow Price Performance

The firm’s 50-day moving average is $33.95.

Heartflow (NASDAQ:HTFL – Get Free Report) last posted its quarterly earnings results on Friday, September 19th. The company reported ($1.46) EPS for the quarter, missing the consensus estimate of ($0.20) by ($1.26). The company had revenue of $43.42 million for the quarter, compared to the consensus estimate of $43.20 million.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. TFC Financial Management Inc. bought a new position in Heartflow in the third quarter worth approximately $40,000. Legal & General Group Plc acquired a new stake in Heartflow in the 3rd quarter valued at $59,000. Y Intercept Hong Kong Ltd acquired a new position in shares of Heartflow during the 3rd quarter worth about $234,000. Legato Capital Management LLC purchased a new position in Heartflow in the 3rd quarter valued at about $243,000. Finally, Sandia Investment Management LP purchased a new stake in Heartflow during the 3rd quarter worth approximately $252,000.

Heartflow Company Profile

(Get Free Report)

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.

See Also